Skip to content
AI IntelligenceAug 8, 2026AI Intelligence
Article

Stanford researchers are running 37,000 AI agents as a virtual biotech, and one of its drug designs was independently confirmed by Merck.

James Zou argues the next frontier is tens of thousands of collaborating agents, not a single more capable model.

Data Cube AI EditorialSource: VentureBeat
01

Source Brief

Stanford researchers are running 37,000 AI agents as a virtual biotech, and one of its drug designs was independently confirmed by Merck. James Zou argues the next frontier is tens of thousands of collaborating agents, not a single more capable model.

02